vs
DHI GROUP, INC.（DHX）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
DHI GROUP, INC.的季度营收约是STANDARD BIOTOOLS INC.的1.6倍（$31.4M vs $19.6M），DHI GROUP, INC.净利率更高（3.0% vs -177.4%，领先180.4%），DHI GROUP, INC.同比增速更快（-9.8% vs -11.5%），DHI GROUP, INC.自由现金流更多（$5.7M vs $-23.1M），过去两年DHI GROUP, INC.的营收复合增速更高（-6.7% vs -12.2%）
DHI集团是总部位于丹麦的国际水环境企业，业务涵盖水环境软件开发与工程咨询，拥有自主水环境建模软件MIKE Powered by DHI，同时为客户提供商业应用、数据门户、运营服务等全链条水环境解决方案。集团目前在全球设有30个分支机构，在新加坡和丹麦都设有研发中心，全球员工约1050名。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
DHX vs LAB — 直观对比
营收规模更大
DHX
是对方的1.6倍
$19.6M
营收增速更快
DHX
高出1.7%
-11.5%
净利率更高
DHX
高出180.4%
-177.4%
自由现金流更多
DHX
多$28.8M
$-23.1M
两年增速更快
DHX
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.4M | $19.6M |
| 净利润 | $951.0K | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 10.4% | -168.5% |
| 净利率 | 3.0% | -177.4% |
| 营收同比 | -9.8% | -11.5% |
| 净利润同比 | -6.9% | -28.8% |
| 每股收益（稀释后） | $0.03 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHXLAB
| Q4 25 | $31.4M | — | ||
| Q3 25 | $32.1M | $19.6M | ||
| Q2 25 | $32.0M | $21.8M | ||
| Q1 25 | $32.3M | $40.8M | ||
| Q4 24 | $34.8M | — | ||
| Q3 24 | $35.3M | $22.1M | ||
| Q2 24 | $35.8M | $22.5M | ||
| Q1 24 | $36.0M | $45.5M |
净利润DHXLAB
| Q4 25 | $951.0K | — | ||
| Q3 25 | $-4.3M | $-34.7M | ||
| Q2 25 | $-841.0K | $-33.5M | ||
| Q1 25 | $-9.4M | $-26.0M | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $-200.0K | $-26.9M | ||
| Q2 24 | $943.0K | $-45.7M | ||
| Q1 24 | $-1.5M | $-32.2M |
毛利率DHXLAB
| Q4 25 | — | — | ||
| Q3 25 | 85.7% | 48.5% | ||
| Q2 25 | 84.0% | 48.8% | ||
| Q1 25 | 83.4% | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 85.6% | 54.9% | ||
| Q2 24 | 85.5% | 46.1% | ||
| Q1 24 | 86.5% | 53.1% |
营业利润率DHXLAB
| Q4 25 | 10.4% | — | ||
| Q3 25 | -14.0% | -168.5% | ||
| Q2 25 | -3.9% | -118.1% | ||
| Q1 25 | -27.5% | -80.8% | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 1.8% | -120.9% | ||
| Q2 24 | 5.6% | -134.5% | ||
| Q1 24 | 5.5% | -132.2% |
净利率DHXLAB
| Q4 25 | 3.0% | — | ||
| Q3 25 | -13.3% | -177.4% | ||
| Q2 25 | -2.6% | -153.7% | ||
| Q1 25 | -28.9% | -63.8% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | -0.6% | -122.0% | ||
| Q2 24 | 2.6% | -203.3% | ||
| Q1 24 | -4.2% | -70.6% |
每股收益（稀释后）DHXLAB
| Q4 25 | $0.03 | — | ||
| Q3 25 | $-0.10 | $-0.09 | ||
| Q2 25 | $-0.02 | $-0.09 | ||
| Q1 25 | $-0.21 | $-0.07 | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.00 | $-0.07 | ||
| Q2 24 | $0.02 | $-0.12 | ||
| Q1 24 | $-0.03 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.5M | $399.7M |
| 总资产 | $188.2M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHXLAB
| Q4 25 | $2.9M | — | ||
| Q3 25 | $2.3M | $129.4M | ||
| Q2 25 | $2.8M | $158.6M | ||
| Q1 25 | $2.7M | $150.9M | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $2.1M | $210.6M | ||
| Q2 24 | $3.0M | $269.8M | ||
| Q1 24 | $3.2M | $287.1M |
总债务DHXLAB
| Q4 25 | — | — | ||
| Q3 25 | $30.0M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $33.0M | — | ||
| Q4 24 | $32.0M | — | ||
| Q3 24 | $32.0M | $55.2M | ||
| Q2 24 | $35.0M | $55.1M | ||
| Q1 24 | $41.0M | $55.0M |
股东权益DHXLAB
| Q4 25 | $94.5M | — | ||
| Q3 25 | $97.3M | $399.7M | ||
| Q2 25 | $102.5M | $424.5M | ||
| Q1 25 | $103.9M | $454.6M | ||
| Q4 24 | $114.3M | — | ||
| Q3 24 | $111.3M | $489.3M | ||
| Q2 24 | $109.8M | $510.3M | ||
| Q1 24 | $106.6M | $577.3M |
总资产DHXLAB
| Q4 25 | $188.2M | — | ||
| Q3 25 | $192.5M | $539.6M | ||
| Q2 25 | $204.9M | $557.0M | ||
| Q1 25 | $212.1M | $579.6M | ||
| Q4 24 | $221.4M | — | ||
| Q3 24 | $219.4M | $681.5M | ||
| Q2 24 | $224.4M | $708.7M | ||
| Q1 24 | $231.9M | $777.7M |
负债/权益比DHXLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.29× | 0.11× | ||
| Q2 24 | 0.32× | 0.11× | ||
| Q1 24 | 0.38× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.2M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $-23.1M |
| 自由现金流率自由现金流/营收 | 18.1% | -118.1% |
| 资本支出强度资本支出/营收 | 4.9% | 4.5% |
| 现金转化率经营现金流/净利润 | 7.60× | — |
| 过去12个月自由现金流最近4个季度 | $13.8M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流DHXLAB
| Q4 25 | $7.2M | — | ||
| Q3 25 | $4.8M | $-22.2M | ||
| Q2 25 | $6.9M | $-20.7M | ||
| Q1 25 | $2.2M | $-30.3M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $5.5M | $-27.9M | ||
| Q2 24 | $9.1M | $-39.0M | ||
| Q1 24 | $2.1M | $-62.5M |
自由现金流DHXLAB
| Q4 25 | $5.7M | — | ||
| Q3 25 | $3.2M | $-23.1M | ||
| Q2 25 | $4.8M | $-22.6M | ||
| Q1 25 | $88.0K | $-35.3M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $2.3M | $-30.1M | ||
| Q2 24 | $5.6M | $-41.0M | ||
| Q1 24 | $-2.4M | $-63.3M |
自由现金流率DHXLAB
| Q4 25 | 18.1% | — | ||
| Q3 25 | 9.9% | -118.1% | ||
| Q2 25 | 15.1% | -103.6% | ||
| Q1 25 | 0.3% | -86.6% | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 6.5% | -136.4% | ||
| Q2 24 | 15.6% | -182.2% | ||
| Q1 24 | -6.5% | -138.9% |
资本支出强度DHXLAB
| Q4 25 | 4.9% | — | ||
| Q3 25 | 5.0% | 4.5% | ||
| Q2 25 | 6.3% | 8.7% | ||
| Q1 25 | 6.7% | 12.4% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.2% | 10.2% | ||
| Q2 24 | 9.7% | 8.6% | ||
| Q1 24 | 12.3% | 1.7% |
现金转化率DHXLAB
| Q4 25 | 7.60× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.61× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHX
| Clearance Jobs | $17.4M | 56% |
| Clearance Jobs Segment | $13.9M | 44% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
